NIH Clinical Trial Number 12-I-0133 can now be followed by going to the NIH Clinical Studies Site and simply typing in Arikace. Then just click on the "12-I-0133" number at it takes you right to the NIH protocol and info location. The only difference that I can see is that the change in eligibility to "patients up to 85 years of age" that was amended into the ClinicalTrialsDOTgov is not in the NIH protocol. I am going to start tracking Dr. Olivier to see if an abstract pops up.
One of the largest investors sold half his stake a few weeks ago.As of now there are no analysts ( Since Wedbush and RBC are has beens.
No one knows the market size for the indications pursued,but it is obvious,Investment firms,the medical press at large are taking a wait & see attitude,...with the next big thing always seeming to be coming down the pike.
Most traders dont dik around with such a low volume bio, but I have and have done well.
A long position imo is at risk here.
Not to worry or thumb !@#, I think there are larger financial issues ahead before Insmed completes trialing and therfore,the stock and the markets may (will ) dictate a much lower price. imo
I think there is plenty of time to invest here ....should those results and analysts say..wow Insmed !
keep your fingers crossed and your thumbs out of your aurse